Insight 2811 Inc’s ResMed RMD Stock Holding History

Insight 2811 Inc’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,122	Closed	-$514K	–	101
2016 Q2	$514K	Sell	8,122 -701	-8%	-$41.3K	0.2%	72
2016 Q1	$510K	Sell	8,823 -588	-6%	-$33.3K	0.2%	73
2015 Q4	$505K	Hold	9,411	–	–	0.24%	70
2015 Q3	$480K	Sell	9,411 -18	-0.2%	-$969	0.28%	68
2015 Q2	$532K	Sell	9,429 -53	-0.6%	-$3.35K	0.25%	75
2015 Q1	$681K	Sell	9,482 -1,652	-15%	-$107K	0.32%	61
2014 Q4	$624K	Sell	11,134 -235	-2%	-$12.3K	0.3%	65
2014 Q3	$560K	Sell	11,369 -193	-2%	-$9.83K	0.24%	74
2014 Q2	$585K	Buy	+11,562	New	+$573K	0.25%	74

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Insight 2811 Inc's RMD Position: Q3 2016 in Review

Insight 2811 Inc sold out of ResMed (RMD) in Q3 2016, closing a stake of 8,122 shares — an estimated $514K sold.

Insight 2811 Inc first reported a position in RMD in Q2 2014 and held it in 9 quarters. The position peaked at $681K in Q1 2015. 373 funds tracked by Wall St. Rank hold RMD as of Q3 2016.

Insight 2811 Inc reported no remaining ResMed position as of Q3 2016 after selling out during the quarter.
Insight 2811 Inc sold 8,122 ResMed shares in Q3 2016, an estimated $514K.
Insight 2811 Inc first reported a position in ResMed in Q2 2014 and held it in 9 quarters.
Insight 2811 Inc's ResMed position peaked at $681K in Q1 2015.
373 funds tracked by Wall St. Rank held ResMed as of Q3 2016.

Based on Insight 2811 Inc's 13F filing for Q3 2016, filed 25 Oct 2016.